The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Clinical research

Immunosuppressive oral prednisone after percutaneous interventions in patients with multi-vessel coronary artery disease. The IMPRESS-2/MVD study

EuroIntervention 2005;1:173-180 - DOI10.4244/EIJV1I2A28.

1. Catheterisation Laboratory of the Division of Cardiology, Universita’ del Piemonte Orientale, Ospedale Maggiore della Carita’, Novara, the Division of Cardiac Surgery, Universita’ Tor Vergata, Rome, Italy. 2. Ospedale San Giovanni, Rome, Italy. 3. Inst

Aims: To assess efficacy and safety of oral treatment with prednisone at immunosuppressive dose after percutaneous coronary interventions (PCI) in patients with multi-vessel coronary artery

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Drug-eluting stent-supported percutaneous coronary intervention in high risk patients refused cardiac surgery

Latest news